195 related articles for article (PubMed ID: 26676746)
21. CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1.
Belizaire R; Koochaki SHJ; Udeshi ND; Vedder A; Sun L; Svinkina T; Hartigan C; McConkey M; Kovalcik V; Bizuayehu A; Stanclift C; Schenone M; Carr SA; Padron E; Ebert BL
Blood; 2021 Apr; 137(16):2209-2220. PubMed ID: 33512474
[TBL] [Abstract][Full Text] [Related]
22. Cbl-mediated K63-linked ubiquitination of JAK2 enhances JAK2 phosphorylation and signal transduction.
Liu CS; Yang-Yen HF; Suen CS; Hwang MJ; Yen JJ
Sci Rep; 2017 Jul; 7(1):4613. PubMed ID: 28676638
[TBL] [Abstract][Full Text] [Related]
23. Casitas B-lineage lymphoma mutants activate AKT to induce transformation in cooperation with class III receptor tyrosine kinases.
Polzer H; Janke H; Schmid D; Hiddemann W; Spiekermann K
Exp Hematol; 2013 Mar; 41(3):271-80.e4. PubMed ID: 23127761
[TBL] [Abstract][Full Text] [Related]
24. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.
Vennin C; Spruyt N; Dahmani F; Julien S; Bertucci F; Finetti P; Chassat T; Bourette RP; Le Bourhis X; Adriaenssens E
Oncotarget; 2015 Oct; 6(30):29209-23. PubMed ID: 26353930
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR Dysregulation and Signaling in Lung Adenocarcinoma.
Hong SY; Kao YR; Lee TC; Wu CW
Cancer Res; 2018 Sep; 78(17):4984-4996. PubMed ID: 29945960
[TBL] [Abstract][Full Text] [Related]
26. Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia.
Caligiuri MA; Briesewitz R; Yu J; Wang L; Wei M; Arnoczky KJ; Marburger TB; Wen J; Perrotti D; Bloomfield CD; Whitman SP
Blood; 2007 Aug; 110(3):1022-4. PubMed ID: 17475912
[TBL] [Abstract][Full Text] [Related]
27. CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases.
Tan YH; Krishnaswamy S; Nandi S; Kanteti R; Vora S; Onel K; Hasina R; Lo FY; El-Hashani E; Cervantes G; Robinson M; Hsu HS; Kales SC; Lipkowitz S; Karrison T; Sattler M; Vokes EE; Wang YC; Salgia R
PLoS One; 2010 Jan; 5(1):e8972. PubMed ID: 20126411
[TBL] [Abstract][Full Text] [Related]
28. SERPINE2 promotes liver cancer metastasis by inhibiting c-Cbl-mediated EGFR ubiquitination and degradation.
Zhang S; Jia X; Dai H; Zhu X; Song W; Bian S; Wu H; Chen S; Tang Y; Chen J; Jin C; Zhou M; Xie H; Zheng S; Song P
Cancer Commun (Lond); 2024 Mar; 44(3):384-407. PubMed ID: 38407942
[TBL] [Abstract][Full Text] [Related]
29. c-Cbl ubiquitin ligase regulates focal adhesion protein turnover and myofibril degeneration induced by neutrophil protease cathepsin G.
Rafiq K; Guo J; Vlasenko L; Guo X; Kolpakov MA; Sanjay A; Houser SR; Sabri A
J Biol Chem; 2012 Feb; 287(8):5327-39. PubMed ID: 22203672
[TBL] [Abstract][Full Text] [Related]
30. RASopathy-associated CBL germline mutations cause aberrant ubiquitylation and trafficking of EGFR.
Brand K; Kentsch H; Glashoff C; Rosenberger G
Hum Mutat; 2014 Nov; 35(11):1372-81. PubMed ID: 25178484
[TBL] [Abstract][Full Text] [Related]
31. Met kinase-dependent loss of the E3 ligase Cbl in gastric cancer.
Lai AZ; Durrant M; Zuo D; Ratcliffe CD; Park M
J Biol Chem; 2012 Mar; 287(11):8048-59. PubMed ID: 22262855
[TBL] [Abstract][Full Text] [Related]
32. [Expressions of c-Cbl, Cbl-b and EGFR and its role of prognosis in NSCLC].
Jiao X; Jin B; Qu X; Yan S; Hou K; Liu Y; Hu X
Zhongguo Fei Ai Za Zhi; 2011 Jun; 14(6):512-7. PubMed ID: 21645455
[TBL] [Abstract][Full Text] [Related]
33. Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl.
Dou H; Buetow L; Hock A; Sibbet GJ; Vousden KH; Huang DT
Nat Struct Mol Biol; 2012 Jan; 19(2):184-92. PubMed ID: 22266821
[TBL] [Abstract][Full Text] [Related]
34. Casitas B-lineage lymphoma linker helix mutations found in myeloproliferative neoplasms affect conformation.
Buetow L; Tria G; Ahmed SF; Hock A; Dou H; Sibbet GJ; Svergun DI; Huang DT
BMC Biol; 2016 Sep; 14(1):76. PubMed ID: 27609087
[TBL] [Abstract][Full Text] [Related]
35. c-Cbl, a ubiquitin E3 ligase that targets active β-catenin: a novel layer of Wnt signaling regulation.
Chitalia V; Shivanna S; Martorell J; Meyer R; Edelman E; Rahimi N
J Biol Chem; 2013 Aug; 288(32):23505-17. PubMed ID: 23744067
[TBL] [Abstract][Full Text] [Related]
36. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1.
Levkowitz G; Waterman H; Ettenberg SA; Katz M; Tsygankov AY; Alroy I; Lavi S; Iwai K; Reiss Y; Ciechanover A; Lipkowitz S; Yarden Y
Mol Cell; 1999 Dec; 4(6):1029-40. PubMed ID: 10635327
[TBL] [Abstract][Full Text] [Related]
37. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
[TBL] [Abstract][Full Text] [Related]
38. Weak binding to E3 ubiquitin ligase c-Cbl increases EGFRvA protein stability.
Song F; Zhou M; Wang B; Shi B; Jiang H; Zhang J; Li Z
FEBS Lett; 2016 May; 590(9):1345-53. PubMed ID: 27059931
[TBL] [Abstract][Full Text] [Related]
39. ErbB2 and ErbB4 Cbl binding sites can functionally replace the ErbB1 Cbl binding site.
Jansen SM; Sleumer LS; Damen E; Meijer IM; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2009 May; 21(5):810-8. PubMed ID: 19263517
[TBL] [Abstract][Full Text] [Related]
40. EGFRvIII undergoes activation-dependent downregulation mediated by the Cbl proteins.
Davies GC; Ryan PE; Rahman L; Zajac-Kaye M; Lipkowitz S
Oncogene; 2006 Oct; 25(49):6497-509. PubMed ID: 16702950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
